Introduction: Olfactory dysfunction has been shown to be an early sign of neurodegenerative disease, but the incidence of neurodegenerative disease in patients with olfactory dysfunction in Japan is unknown. Moreover, olfactory dysfunction has been suggested to be a predictor of mortality. The goal of the present study was to investigate the long term olfactory prognosis, incidence of neurodegenerative disease and mortality in patients with olfactory dysfunction.
Methods: A cross-sectional study was performed in patients with olfactory dysfunction who presented at the Department of Otorhinolaryngology of The Jikei University Hospital from April 2009 to March 2012. Of 228 patients, 167 with known street addresses were mailed questionnaires from December 2016 to March 2017. The survey asked about death, newly diagnosed diseases, and the current visual analogue scale of olfactory symptoms since the patient had been treated at our hospital. If the patient could not answer due to death or other factors, family members were permitted to answer. Information on age, sex, duration of symptoms, visual analogue scale, and the results of the initial olfactory examination was obtained from hospital records. The patient was enrolled in the study if their completed questionnaire was returned by May 2017 and consent was provided.
Results: Completed questionnaires were returned and consent to the study was given for 86 patients (34 males, 52 females; mean age, 58.3 years). In these patients, olfactory dysfunction was idiopathic in 11 cases, and was due to chronic sinusitis in 37 and viral infection in 19. A neurodegenerative disease (Parkinson’s disease) had been diagnosed in 2 of the patients with idiopathic olfactory dysfunction. Two patients had died prior to return of the questionnaires. The causes of death were unclear, but both patients had been diagnosed with cancer.
Conclusion: Parkinson’s disease reportedly occurs in 2 of the patients with idiopathic olfactory dysfunction. Therefore, if idiopathic olfactory dysfunction is diagnosed, symptoms of other neurodegenerative disorders, such as autonomic dysfunction, and other cognitive disorders should be assessed to rule out a neurodegenerative disease. Neurologists should also be consulted in such cases. The mortality rate in the present study was 2.3%. The relevance of olfactory dysfunction to death was not confirmed; however, if symptoms are chronic and cancer has been diagnosed, quality of life and activities of daily living of the patient require careful attention.
View full abstract